Cell Line Development Market

Government organizations focusing more on drug discovery and development

In the search of new treatment pathway for the diseases like cancer and neurological disorder, researcher are focusing on cell biology and in-vitro cell culture. Furthermore government activities pertaining to development of biologics, and vaccines and growing awareness relating to monoclonal antibodies application in oncology, auto-immune diseases are expected to drive the growth of provincial business in cell line development market.

In developing countries several government initiatives such as improvement in healthcare infrastructure and launch of public healthcare programs leads the growth of biotechnology sector thereby boosting the growth cell line development market

Regenerative medicines – the next generation treatment solution

Regenerative medicines deals with the process to regrow, repair and replace damaged and diseased cells, tissues, and organs which has been lost due to age, disease, damage, or congenital defects. Regenerative medicines are the next generation treatment solution and Cell Line Development is an invariable part of regenerative medicine. For example stem cells are used as a tool in regenerative medicines.

Adult stem cells are easily available in human body and are used to stem cells to repair itself. Adult stem cells can be collected from cord blood, bone marrow, dental pulp and other sources. Thus, the introduction of novel product line in regenerative medicine segment is anticipate to increase the demand for cell line development during the forecast period.

Download a Comprehensive Report Snapshot

Increasing demand for biopharmaceuticals

Biopharmaceuticals therapeutic drugs are manufactured through genetic manipulation of organism or living cells. Additionally patent expiry of branded therapeutics leads to increase in development of biosimilars thereby increase the revenue opportunity in overall cell line development market.

The growing use of biological therapeutics in treating chronic diseases, like cancer, arthritis diabetes and rare diseases are majorly influencing the development of biopharmaceuticals. Additionally, the appearance of high-expressing cell lines is further boosting the growth of cell line development market.

Increasing focus on cancer research

Cell based assay involving in vitro cancer cell culture are required for cancer research and development activities. National Cancer Institute (NCI) alongside different organizations invests in R&D activities to encourage and bolster the cancer research.

For example, Cancer Moonshot, The RAS Initiative, National Clinical Trials Network (NCTN), NCI Community Oncology Research Program (NCORP), NCI Genomic Data Commons (GDC) and so on. Such government and non-government organization’s initiatives on cancer research positively impacting the Cell Line Development Market.

Increase in outsourcing by pharmaceutical and biotechnological companies

The biotechnological and pharmaceutical companies are focusing on outsourcing their research and development operation to different contract research organizations (CROs). The rising global cost pressure on governments for cost effective biopharmaceuticals and changing political scenario across the globe forced these companies to take engaged into development of novel, cost effective biological products.

Moreover various CROs are predominantly using in-vitro cell culture to increase the production of biologics and biopharmaceuticals which is anticipate to increase the demand for cell line development market. Cell Line Development market would pre-dominated by biopharmaceutical contract manufacturing companies. Both industrial and research verticals are in search of better and advanced cell lines to develop novel therapeutic proteins, drugs, vaccines, and biosimilars. This has led to a better prospect for growth of cell line development market over the forecast period.

Competitive Landscape

Competition section of the cell line development market features profiles of key players operating in the cell line development market based on company shares, differential strategies, cell line development product offerings, marketing approach and company dashboard.

Some of the key players featured in this report include Danaher Corporation, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., Lonza (Sartorius Stedim Biotech S.A.), Merck KGaA, American Type Culture Collection (ATCC), WuXi Biologics, Selexis SA.

Lonza (Sartorius Stedim Biotech S.A.) offers a range of products for cell line development, which include culture media & reagents, primary and stem cells and CellBio Services. Selexis SA has CHO-K1 cell line in their product cell line development portfolio

The key manufacturers of cell line development are focusing on novel marketing strategies to increase product penetration. Most of the companies are focusing on acquisitions, mergers, expansion, launches and agreements as the key strategies increase the sale of their cell line products in different geographies.

Definition

Cell Line Development is the procedure by which cells are developed under controlled conditions, for the most part outside their common habitat. Cell line development have variety of application in healthcare and life science industry such as drug screening, drug development, production of bio production

About the Report

Research study have been conducted on cell line development market size for the forecast period 2018 to 2028. The cell line development market report offers a comprehensive evaluation of the business opportunities prevailing in the cell line development market along with insights on the trend, market dynamics, cell line development market size opportunity analysis and cell line development market competition. The report elaborates on the macroeconomic factors influencing the dynamics of cell line development market and its futuristic potential of cell line development.

Additional Questions Answered

Some of the additional questions addressed in this report on cell line development market-

• What is the revenue potential of care cell line development market size across regions of North America and Europe?
• Who are the key competitors and what are their portfolios in cell line development market?
• What are major challenges influencing the growth of cell line development market?
• How intervention from regulatory authority is shaping the cell line development market growth?

Research Methodology

The cell line development market has been estimated based on supply-demand approach. A triangulation methodology is adopted to derive the market size, which is primarily based on overall expenditure on life science research and R&D funding to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services.

This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

The research study on cell line development market also includes top trends and macro as well as micro economic factors shaping the cell line development market. With this approach, the report on cell line development market anticipates the industry attractiveness of every major segment in cell line development over the forecast period.

Segmentation

The report offers a comprehensive taxonomy of cell line development market based on product type, source type, end user, type of cell line and region. Cell line development products includes media and reagents, equipment and accessories. Cell lines can be derived from mammalian cell lines and non-mammalian cell lines as well. There are various cell lines available in the cell line development market such as Recombinant cell lines, hybridomas, continuous cell lines and primary cell lines.

End-use segments in cell line development market which are a part of this cell line development market report include biopharmaceutical companies, contract research organizations, academics and research institutes and biotechnology companies. The cell line development market has been analyzed across regions of North America, Latin America, Europe, CIS and Russia, Asia Pacific Excluding Japan, Japan and MEA.